On The Brink: Medical Breakthrough Developed By This Leading Company

On The Brink: Medical Breakthrough Developed By This Leading Company.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

Cybin Inc. (NASDAQ: CYBN) (CBOE: CYBN), a leading biotech company in the psychedelics sector, has recently announced groundbreaking Phase 2 interim results for its proprietary deuterated psilocybin analog, CYB…